NEOS Stock Price Increases Over 60% Pre-Market: Why It Happened

By Amit Chowdhry ● Mar 18, 2021
  • The stock price of Neos Therapeutics Inc (NASDAQ: NEOS) has increased by over 60% pre-market. This is why it happened.

The stock price of Neos Therapeutics Inc (NASDAQ: NEOS) – a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products – has increased by over 60% pre-market. Investors appear to be responding to the special meeting of shareholders happening today. 

Aytu BioScience (a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs) and Neos Therapeutics announced last month that the companies’ respective special meetings of stockholders related to the proposed merger between Aytu and Neos were set for Thursday, March 18, 2021. And stockholders of record of each company as of February 5, 2021, will be eligible to receive notice of and to vote at their respective company’s special meeting.

Following stockholder approval and the satisfaction or waiver of the other conditions to the closing of the merger, the combined company will be renamed Aytu Biopharma, Inc., and its common stock will continue to trade under the symbol “AYTU” on the Nasdaq Capital Market.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.